Change in the Management of TSS

The TSS company logo, representing a change in the company's management.
We are thrilled to announce a new chapter at TSS as we bid farewell to our esteemed CEO, Niclas Ohlsson.

After 16 years of dedicated service as our Chief Executive Officer (CEO), Niclas Ohlsson has made the decision to step down to prioritize his well-being following a recent health scare. Niclas has been instrumental in shaping TSS into a leading company within the industry, and we are truly grateful for his years of hard work and leadership.

Stepping into the role of CEO is Tobias Holmer, our CTO for the past 9 years and interim CEO for the last 7 months. Tobias's wealth of experience and forward-thinking leadership have already positively impacted our organization, and we are enthusiastic about the exciting future under his guidance.

We are excited to continue our mission of delivering the highest standards in temperature monitoring solutions for the pharmaceutical industry.

Join us in wishing Niclas all the best in his future endeavors and thanking him for his remarkable contributions. Here’s to a new era of growth and success with Tobias at the helm!

__wf_reserved_inherit
Tobias Holmer, CEO

You may also be interested in

On-demand webinar: Introducing BLE technology for temperature monitoring

Get introduced to the solution tailored to GxP critical shipments – BLE technology for temperature monitoring
Read moreDownload Whitepaper

How To Minimise the Environmental Impact of Cloud Operations

When people think about sustainability transitions in pharmaceutical supply chains, they often focus on reducing product waste, or optimising transportation. These are both important initiatives, but there's another part of the equation that often goes unnoticed: the digital infrastructure powering modern supply chains.
Read moreDownload Whitepaper

Visibility and automation: reducing disruption due to temperature excursions

The Covid-19 pandemic has placed a global spotlight on pharmaceuticals and the importance of temperature control. The large-scale vaccination programs being rolled out across the world depend on operators and distributors being able to monitor and manage temperatures effectively. It has also shown just how challenging this can be.
Read moreDownload Whitepaper

You may also be interested in

A clinical trial supply chain diagram over a stack of paperwork, representing the need for automation.

Future-Proofing Clinical Trials: How Sponsors Can Up-Scale Through Automation

At this year’s Clinical Trial Supply Europe event in Barcelona, TSS took center stage to discuss one of the most pressing challenges in clinical trial supply chains—temperature monitoring. Our Key Account Manager, Anita Leposa, highlighted how automation is revolutionizing temperature integrity management, reducing manual work, and ensuring compliance for global pharmaceutical sponsors.
Read more

How To Minimise the Environmental Impact of Cloud Operations

When people think about sustainability transitions in pharmaceutical supply chains, they often focus on reducing product waste, or optimising transportation. These are both important initiatives, but there's another part of the equation that often goes unnoticed: the digital infrastructure powering modern supply chains.
Read more

Subscribe to our newsletter

Sign up for our newsletter to receive all the latest TSS news and insights in temperature management solutions.